VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING
K-Number: K122578 · 2013-02-25
Advertisement
Device Summary
Frequently Asked Questions
What is the VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING?
VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING is a medical device that received FDA 510(k) clearance on 2013-02-25. The listed applicant is Vital Images, Inc.. The 510(k) number is K122578.
When did VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING receive FDA 510(k) clearance?
VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING received FDA 510(k) clearance on 2013-02-25, under 510(k) number K122578.
Who is the listed applicant for VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING?
The FDA 510(k) record lists Vital Images, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING?
The FDA product code for VITREA CT TRANSCATHETER AORTIC VALVE REPLACMENT (TAVR) PLANNING is LLZ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Vital Images, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LLZ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement